Pharmaceutical Gelatin Market

Pharmaceutical Gelatin Market by Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry), Application (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat), Function (Stabilizing, Thickening, Gelling), Region - Global Forecast to 2025

Report Code: PH 7750 Sep, 2020, by marketsandmarkets.com

[194 Pages Report]The pharmaceutical gelatin market is projected to reach USD 1.2 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 5.3% during the forecast period. Growth in this market is driven by the versatility and unique functional properties of gelatin in pharmaceutical applications, the increasing demand for gelatin capsules due to rise in chronic illnesses, and the increase in ageing population globally.

Pharmaceutical Gelatin Market

To know about the assumptions considered for the study, Request for Free Sample Report

Covid-19 Impact on the Pharmaceutical Gelatin Market

The rising prevalence of COVID-19 has driven the demand for pharmaceutical industry across the globe. However, the quarantine and lockdown measures imposed in various regions has resulted in transport and logistics issues, causing difficulty in procurement of raw material for pharmaceutical gelatin. This has affected the supply of pharmaceutical gelatin in some regions, resulting in a supply-demand gap. Countries with prolonged periods of lockdown such as India and China have been affected more severely than others, such as, US and countries of the European Union. However, this effect is expected to be temporary and would recover in the post-Covid 19 period as normal operations are reinstated.

Pharmaceutical Gelatin Market Dynamics

Driver: Versatility and superiority of gelatin in pharmaceutical applications

The unique functional capabilities of gelatin such as gelling, adhesion, coating, binding, and film-building makes it highly advantageous for use in the pharmaceutical industry. Gelatin coating on hard capsules, softgel capsules, and tablets not only masks the odor of medicines but also facilitates ease in swallowing. Moreover, the properties of gelatin provide protection against environmental changes associated with oxygen or moisture, thereby increasing the shelf-life of these products. These superior functional properties of gelatin are a driver for the pharmaceutical gelatin market.

Restraint: Increasing popularity of veganism

In recent years, there has been a rising trend in veganism across the world, which is defined as the abstinence from animal-based products. These trends have also extended to the pharmaceutical industry, with capsule manufacturers offering non-gelatin capsules or vegetarian capsules manufactured from purely plant-derived materials to meet the demands of consumers. The increasing demand for plant-based pharmaceutical products and subsequent changes in their product portfolios by capsule manufacturers are expected to restrain the growth of pharmaceutical gelatin during the forecast period.

Opportunity: Rising demand for pharmaceutical-grade gelatin in emerging countries

Emerging economies such as the Asia Pacific, the Middle East, Latin America, and Africa provide significant opportunities for the growth of the market. Global raw gelatin and gelatin capsule manufacturers have been capitalizing on this demand by expanding their business presence and production capacities in these regions. The increasing demand in emerging economies, coupled with lower raw material and labor costs offer an opportunity for the growth of the market during the forecast period.

Challenge: Rising prices and poor availability of raw materials

One of the major challenges facing the global pharmaceutical gelatin market is the procurement of raw material. The main factor affecting the availability of raw materials for the extraction of gelatin is the functional capacity of slaughterhouses and the meat processing industry which varies significantly depending on economic conditions. Moreover, the handling of raw material and production are also governed by strict regulations in various countries to ensure the prevention of the spread of animal-borne diseases. This can can further affect supply in cases of export or import bans or in cases of incidences of these diseases in certain regions at any given time. These factors pose a significant challenge to the growth of the market during the forecast period.

The softgel capsules segment is expected to show the highest growth rate in the pharmaceutical gelatin market, by application, in the forecast period

Based on application, the pharmaceutical gelatin market is segmented into hard capsules, softgel capsules, tablets, absorbable Hemostats, and other applications. The high growth rate of softgel capsules is due to its advantages of being a patient-friendly dosage form due to the capability of being formulated appropriately for rapid or slow release, and high degree of reproducibility. These factors are responsible for the high growth rate of the softgel capsules in the application segment of the pharmaceutical gelatin market in the forecast period.

In the by source segment, porcine source holds the highest share in the pharmaceutical gelatin market in the forecast period

Based on source, the pharmaceutical gelatin market is segmented into porcine, bovine bone, bovine skin, marine & poultry. The porcine segment is estimated to grow at the highest growth during the forecast period. Factors such as its variety of applications in pharmaceutical industry, absorbable hemostats and other biomedical applications, along with lower cost of production and shorter manufacturing cycle are driving the growth of this segment.

The function of gelatin as a thickening agent is growing at the highest rate in the pharmaceutical gelatin market in the forecast period

Based on function, the pharmaceutical gelatin market is segmented into stabilizing agent, thickening agent, gelling agent & other functions. The thickening segment is estimated to grow at the highest growth due to its increasing scope due to its application in medicinal syrups, elixirs, and other liquid dosage forms. Moreover, gelatin is used to increase the viscosity of the dosage form without altering its other properties. The utility of gelatin as a thickening agent in antibiotic creams and lotions are also driving the growth of this segment.

Type B gelatin holds the highest market share in the pharmaceutical gelatin market in the forecast period

Based on type, the pharmaceutical gelatin market is segmented into Type A & Type B. The increasing preference for bovine bone for the manufacture of pharmaceutical gelatin and cultural acceptability of bovine source is driving the growth of the Type B segment in the pharmaceutical gelatin market can be attributed to the high share this segment in the forecast period.

The Asia Pacific region is expected to grow at the highest CAGR during the forecast period

The pharmaceutical gelatin market in the Asia Pacific region is expected to grow at the highest CAGR during the forecast period. In this region, there is ample availability of porcine and bovine source of raw material, low cost of labor and capital investment, due to which major market players are investing in this region. These factors are driving the growth of the Asia Pacific region in the forecast period.

Pharmaceutical Gelatin Market  by Region

Key players in the pharmaceutical gelatin market:

The prominent players in the global pharmaceutical gelatin market include Darling Ingredients Inc. (US), Nitta Gelatin Inc (Japan), Tessenderlo Group (Belgium), Gelita AG (Germany), Weishardt (France), Trobas Gelatine B.V. (Netherlands), Lapi Gelatine S.p.A (Italy), Italgelatine S.p.A (Italy), Xiamen Gelken Gelatin Co. Ltd. (China), Gelco International (Brazil), Aspire Pharmaceuticals. (US), India Gelatine & Chemicals Ltd. (India), Gelnex Industria E Comercio Ltda (Brazil), Junca Gelatines (Spain), Henan Boom Gelatin Co. Ltd (China), Baotou Dongbao Bio-Tech Co. Ltd (China), Norland Products Inc. (US), Geltech Co. Ltd (South Korea), Geliko LLC (US), and Kenney & Ross Limited (Canada).

Scope of the Report:

Report Metric

Details

Market Size available for years

2018–2025

Base Year Considered

2019

Forecast period

2020-2025

Forecast Unit

Value(USD)

Segments covered

Application, Source, Function, Type and Region

Geographies covered

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe(RoE)

Asia Pacific
China
Japan
India
Rest of Asia Pacific (RoAPAC)
Rest of the World(RoW)
Latin America
Middle East & Africa

Companies Covered

Darling Ingredients Inc. (US), Nitta Gelatin Inc (Japan), Tessenderlo Group (Belgium), Gelita AG (Germany), Weishardt (France), Trobas Gelatine B.V. (Netherlands), Lapi Gelatine S.p.A (Italy), Italgelatine S.p.A (Italy), Xiamen Gelken Gelatin Co. Ltd. (China), Gelco International (Brazil), Aspire Pharmaceuticals. (US), India Gelatine & Chemicals Ltd. (India), Gelnex Industria E Comercio Ltda (Brazil), Junca Gelatines (Spain), Henan Boom Gelatin Co. Ltd (China), Baotou Dongbao Bio-Tech Co. Ltd (China), Norland Products Inc. (US), Geltech Co. Ltd (South Korea), Geliko LLC (US), and Kenney & Ross Limited (Canada).

The research report categorizes the market into the following segments and subsegments:

Pharmaceutical Gelatin Market, By Application

  • Hard Capsules
  • Soft Capsules
  • Tablets
  • Absorbable Hemostats
  • Other Applications

Pharmaceutical Gelatin Market, By Source

  • Porcine
  • Bovine Skin
  • Bovine Bone
  • Marine
  • Poultry

Pharmaceutical Gelatin Market, by Function

  • Stabilizing agents
  • Thickening agents
  • Gelling agents & Other Functions

Pharmaceutical Gelatin Market, by Type

  • Type A
  • Type B

Recent Developments

  • In July 2020, Darling Ingredients, Inc. (US) launched X-Pure GelMA, the first Good Manufacturing Practice (GMP)-ready range of gelatin methacryloyl (GelMA) biomaterials suitable for preclinical and clinical applications.
  • In October 2019, Gelita AG (Germany) opened a modern gelatin production facility in Pingyang, China.  
  • In September 2019, Gelnex (Brazil) announced the planned construction of gelatin production facility in Paraguay and Indiana (US) to continue the expansion of its global presence.
  • In December 2018, Gelnex (Brazil) proposed the construction of gelatin manufacturing plant in Portage (US) which would dry gelatin to a powder form for further use in pharmaceutical products.
  • In November 2018, Darling Ingredients, Inc. (US) acquired the stock of PPH Conto Ltd.(Poland), a food-grade animal fat processing facility to enlarge production portfolio with high end food grade fats.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 24)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE PHARMACEUTICAL GELATIN MARKET
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
           1.4.1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 27)
    2.1 RESEARCH APPROACH
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY RESEARCH
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY RESEARCH
           2.1.3 PRIMARY SOURCES
                    2.1.3.1 Key data from primary sources
                    2.1.3.2 Breakdown of Primaries
                               FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION
    2.2 MARKET SIZE ESTIMATION
           FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019)
           FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019)
           FIGURE 5 SUPPLY SIDE ANALYSIS: PHARMACEUTICAL GELATIN MARKET (2019)
           FIGURE 6 APPROACH 3: BASED ON SOURCE, BY REGION (2019)
           FIGURE 7 APPROACH 4: BASED ON RAW MATERIAL UTILIZATION IN GELATIN EMPTY CAPSULES
           FIGURE 8 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
           FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PHARMACEUTICAL GELATIN MARKET (2020-2025)
    2.3 DATA TRIANGULATION APPROACH
           FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 COVID-19 HEALTH ASSESSMENT
    2.7 COVID-19 ECONOMIC ASSESSMENT
    2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
           FIGURE 11 CRITERIA IMPACTING THE GLOBAL ECONOMY
           FIGURE 12 SCENARIOS OF THE RECOVERY OF THE GLOBAL ECONOMY
    2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO PERTAINING TO THE PHARMACEUTICAL GELATIN MARKET

3 EXECUTIVE SUMMARY (Page No. - 42)
    FIGURE 13 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    FIGURE 14 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020 VS. 2025 (USD MILLION)
    FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE PHARMACEUTICAL GELATIN MARKET

4 PREMIUM INSIGHTS (Page No. - 45)
    4.1 PHARMACEUTICAL GELATIN MARKET OVERVIEW
           FIGURE 16 VERSATILITY OF GELATIN IN PHARMACEUTICAL AND BIOMEDICAL APPLICATIONS DRIVING MARKET GROWTH
    4.2 PHARMACEUTICAL GELATIN MARKET:  GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 17 INDIA PROJECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
    4.3 REGIONAL MIX: PHARMACEUTICAL GELATIN MARKET  (2020–2025)
           FIGURE 18 ASIA PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD (2020–2025)
    4.4 PHARMACEUTICAL GELATIN MARKET: DEVELOPED  VS. EMERGING MARKETS, 2020 VS. 2025 (USD MILLION)
           FIGURE 19 EMERGING MARKETS TO GROW AT HIGHER CAGRS DURING THE STUDY PERIOD

5 MARKET OVERVIEW (Page No. - 48)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 20 PHARMACEUTICAL GELATIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Versatility and superiority of gelatin in pharmaceutical applications
                               FIGURE 21 MEAN PERCENTAGE OF RIBOFLAVIN RELEASED FROM GELATIN, HPMC (1ST GENERATION), AND PULLULAN CAPSULES IN 0.1 M HCL BUFFER
                    5.2.1.2 Gelatin is an all-natural product fulfilling pharmaceutical regulations
           5.2.2 RESTRAINTS
                    5.2.2.1 Increasing popularity of veganism
                               FIGURE 22 UK: RISING TREND OF VEGANISM FROM 2014 TO 2019 (‘000)
                    5.2.2.2 Cultural restrictions limit the growth of pharmaceutical gelatin in certain regions
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Rising demand for pharmaceutical-grade gelatin in emerging countries
                    5.2.3.2 Enhancements in the properties of gelatin broaden the scope of its pharmaceutical applications
           5.2.4 CHALLENGES
                    5.2.4.1 Increasing incidences of animal-borne diseases
                               FIGURE 23 CHINA: PORK IMPORTS (2018-2020)
                               FIGURE 24 CHINA: PER CAPITA PORK AVAILABILITY PER PERSON (2018-2020)
                    5.2.4.2 Rising prices and poor availability of raw materials
    5.3 PORTER’S FIVE FORCES ANALYSIS
           TABLE 1 PORTER’S FIVE FORCES ANALYSIS
           5.3.1 THREAT OF NEW ENTRANTS
           5.3.2 THREAT OF SUBSTITUTES
           5.3.3 BARGAINING POWER OF SUPPLIERS
           5.3.4 BARGAINING POWER OF BUYERS
           5.3.5 COMPETITIVE RIVALRY
    5.4 TRENDS IN AVERAGE SELLING PRICE
           TABLE 2 AVERAGE SELLING PRICE OF PHARMACEUTICAL GELATIN, BY REGION, 2019-2020
    5.5 VALUE CHAIN ANALYSIS
           FIGURE 25 VALUE CHAIN ANALYSIS: PHARMACEUTICAL GELATIN MARKET
           5.5.1 SOURCING OF RAW MATERIAL
           5.5.2 COLLECTION AND TRANSPORT OF RAW MATERIAL
           5.5.3 RAW MATERIAL PREPARATION AND PROCESSING
           5.5.4 GELATIN PRODUCTION
           5.5.5 DISTRIBUTION TO END USERS
    5.6 ECOSYSTEM MAP
           FIGURE 26 ECOSYSTEM: PHARMACEUTICAL GELATIN MARKET
           5.6.1 INTRODUCTION
           5.6.2 FARMING INPUT
           5.6.3 FARMING
           5.6.4 SLAUGHTERING
           5.6.5 MANUFACTURING
           5.6.6 SUPPLIERS/DISTRIBUTORS
           5.6.7 END-PRODUCT MANUFACTURERS
    5.7 KEY MARKETS FOR IMPORT/EXPORT
           5.7.1 US
           5.7.2 CHINA
           5.7.3 BRAZIL
                    TABLE 3 IMPORTS & EXPORTS OF GELATIN, BY COUNTRY: (2018/2019) UNITS – 1,000 TONS

6 INDUSTRY INSIGHTS (Page No. - 62)
    6.1 INTRODUCTION
    6.2 INDUSTRY TRENDS
           6.2.1 PRODUCT INNOVATIONS OVERCOME CROSSLINKING OF GELATIN
           6.2.2 INCREASING BIOMEDICAL APPLICATIONS OF GELATIN
           6.2.3 INSIGHTS ON THE CONVERSION OF GELATIN TO COLLAGEN PEPTIDE AND PHARMACEUTICAL GELATIN
    6.3 IMPACT OF THE COLLAGEN PEPTIDES MARKET ON PHARMACEUTICAL GELATIN
    6.4 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET
    6.5 REGULATORY ANALYSIS

7 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION (Page No. - 68)
    7.1 INTRODUCTION
           TABLE 4 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
    7.2 HARD CAPSULES
           7.2.1 COST-EFFECTIVITY OF GELATIN HARD CAPSULES DRIVES THE GROWTH OF THIS SEGMENT
                    TABLE 5 TYPICAL HARD GELATIN CAPSULE COMPOSITION
                    TABLE 6 DIMENSIONS (IN MILLIMETERS) OF TWO-PIECE HARD CAPSULES
                    TABLE 7 HARD CAPSULES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    7.3 SOFTGEL CAPSULES
           7.3.1 RISING APPLICATIONS OF SOFTGEL CAPSULES INCREASE THEIR DEMAND IN THE PHARMACEUTICAL GELATIN MARKET
                    TABLE 8 DIFFERENCES BETWEEN HARD CAPSULES AND SOFTGEL CAPSULES
                    TABLE 9 SOFTGEL CAPSULES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    7.4 TABLETS
           7.4.1 THE APPLICATION OF GELATIN IN TABLET BINDING AND COATING IS EXPECTED TO INCREASE DURING THE FORECAST PERIOD
                    TABLE 10 IN VITRO PROPERTIES OF TABLET WITH GELATIN AS BINDER  (CONCENTRATIONS 2.0-8.0%)
                    TABLE 11 TABLETS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    7.5 ABSORBABLE HEMOSTATS
           7.5.1 INCREASING APPLICATIONS OF GELATIN IN ABSORBABLE HEMOSTATS DUE TO BIOCOMPATIBILITY TO DRIVE THE GROWTH OF THIS SEGMENT
                    TABLE 12 ABSORBABLE HEMOSTATS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    7.6 OTHER APPLICATIONS
           7.6.1 VERSATILITY OF GELATIN DUE TO ITS UNIQUE FUNCTIONAL PROPERTIES BOOSTS ITS SCOPE FOR APPLICATIONS ACROSS THE PHARMACEUTICAL INDUSTRY
                    TABLE 13 OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
    7.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET, BY APPLICATION

8 PHARMACEUTICAL GELATIN MARKET, BY SOURCE (Page No. - 78)
    8.1 INTRODUCTION
           8.1.1 GELATIN: REGULATIONS IMPLEMENTED BY DIFFERENT REGIONS/COUNTRIES
                    TABLE 14 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                    TABLE 15 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2025 (KT)
    8.2 PORCINE
           8.2.1 LOWER MANUFACTURING COSTS OF PORCINE RAW MATERIAL TO DRIVE THE GROWTH OF THIS SEGMENT
                    TABLE 16 US: PORK EXPORTS IN USD MILLION (2019)
                    TABLE 17 PORCINE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 18 PORCINE MARKET, BY REGION, 2018–2025 (KT)
    8.3 BOVINE SKIN
           8.3.1 INCREASING AVAILABILITY OF BOVINE SKIN TO BOOST APPLICATION IN THE PHARMACEUTICAL GELATIN MARKET
                    TABLE 19 US: EXPORT STATISTICS FOR BOVINE FRESH/WET SALTED HIDES (NUMBER OF PIECES)
                    TABLE 20 US: EXPORT STATISTICS FOR BOVINE FRESH/WET SALTED HIDES (VALUE IN USD THOUSAND)
                    TABLE 21 BOVINE SKIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 22 BOVINE SKIN MARKET, BY REGION, 2018–2025 (KT)
    8.4 BOVINE BONE
           8.4.1 RISING PREFERENCE FOR BOVINE BONE AS RAW MATERIAL IN THE PHARMACEUTICAL GELATIN MARKET DUE TO LOW BLOOM AND HIGH VISCOSITY
                    TABLE 23 BOVINE BONE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 24 BOVINE BONE MARKET, BY REGION, 2018–2025 (KT)
    8.5 MARINE
           8.5.1 RISING INCIDENCE OF ZOONOTIC DISEASES IN CATTLE AND PIGS TO DRIVE THE GROWTH OF MARINE SOURCE IN THE PHARMACEUTICAL GELATIN MARKET
                    TABLE 25 MARINE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 26 MARINE MARKET, BY REGION, 2018–2025 (KT)
    8.6 POULTRY
           8.6.1 STEADY AVAILABILITY OF POULTRY AS RAW MATERIAL IS EXPECTED TO BOOST UTILITY AS RAW MATERIAL IN THE PHARMACEUTICAL GELATIN MARKET
                    TABLE 27 AMINO ACID COMPOSITION OF GELATIN FROM DIFFERENT SOURCES
                    TABLE 28 POULTRY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 29 POULTRY MARKET, BY REGION, 2018–2025 (KT)
    8.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET, BY SOURCE
           FIGURE 27 BEEF EXPORTS FROM BRAZIL (1,000 TONS)

9 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION (Page No. - 91)
    9.1 INTRODUCTION
           FIGURE 28 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION
    9.2 BLOOM VALUE
           9.2.1 HIGH BLOOM
           9.2.2 LOW BLOOM
                    TABLE 30 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2025 (USD MILLION)
    9.3 STABILIZING AGENTS
           9.3.1 THE HIGH SHARE OF GELATIN IN THIS SEGMENT CAN BE ATTRIBUTED TO UTILITY AS A STABILIZING AGENT FOR CAPSULES AND VACCINES
                    TABLE 31 STABILIZING AGENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    9.4 THICKENING AGENTS
           9.4.1 THE RISING USE OF SYRUPS AND LIQUID DOSAGE FORMS TO DRIVE THE GROWTH OF THIS FUNCTIONAL SEGMENT IN THE PHARMACEUTICAL GELATIN MARKET
                    FIGURE 29 VISCOSITY BEHAVIOR OF GELATIN AS A FUNCTION OF TEMPERATURE AT 60OC
                    TABLE 32 THICKENING AGENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    9.5 GELLING AGENTS & OTHER FUNCTIONS
           9.5.1 THE UNIQUE GELLING PROPERTY OF GELATIN FINDS A SIGNIFICANT NUMBER OF APPLICATIONS IN THE FORMATION OF SOFTGEL CAPSULES AND HEMOSTATS
                    TABLE 33 GELLING AGENTS & OTHER FUNCTIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)

10 PHARMACEUTICAL GELATIN MARKET, BY TYPE (Page No. - 98)
     10.1 INTRODUCTION
               FIGURE 30 PRODUCTION PROCESS: TYPE A AND TYPE B GELATIN
               TABLE 34 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: HARD CAPSULES
               TABLE 35 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: SOFTGEL CAPSULES
               TABLE 36 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: TABLET GELATIN
               TABLE 37 PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
     10.2 TYPE B
             10.2.1 THE RISING DEMAND FOR BOVINE SOURCE RAW MATERIAL PROJECTED TO DRIVE THE GROWTH OF TYPE B GELATIN DURING THE FORECAST PERIOD
                       TABLE 38 NUTRITIONAL COMPOSITION OF TYPE B GELATIN
                       TABLE 39 TYPE B GELATIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
     10.3 TYPE A
             10.3.1 COST-EFFECTIVENESS OF PROCESSING TYPE A GELATIN IS FAVORING GROWTH IN THE MARKET
                       TABLE 40 NUTRITIONAL COMPOSITION OF TYPE A GELATIN
                       TABLE 41 TYPE A GELATIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)

11 PHARMACEUTICAL GELATIN MARKET, BY REGION (Page No. - 104)
     11.1 INTRODUCTION
               FIGURE 31 INDIA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD IN THE PHARMACEUTICAL GELATIN MARKET (IN TERMS OF VALUE)
               TABLE 42 PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
               TABLE 43 PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2025 (KT)
     11.2 NORTH AMERICA
             11.2.1 THE LARGE MARKET SHARE OF THE NORTH AMERICAN REGION CAN BE ATTRIBUTED TO THE HIGH R&D INVESTMENTS
                       FIGURE 32 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
                       TABLE 44 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY,  2018–2025 (USD MILLION)
                       TABLE 45 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION,  2018–2025 (USD MILLION)
                       TABLE 46 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,  2018–2025 (USD MILLION)
                       TABLE 47 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,  2018–2025 (USD MILLION)
                       TABLE 48 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE,  2018–2025 (USD MILLION)
             11.2.2 US
                       11.2.2.1 Rising concerns in arthritis and obesity to drive the gelatin market in the US
                                   TABLE 49 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 50 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
                                   TABLE 51 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
                                   TABLE 52 US: PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             11.2.3 CANADA
                       11.2.3.1 Rising domestic demand for pharmaceutical products to drive the growth of the pharmaceutical gelatin market
                                   TABLE 53 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION,  2018–2025 (USD MILLION)
                                   TABLE 54 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
                                   TABLE 55 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,  2018–2025 (USD MILLION)
                                   TABLE 56 CANADA: PHARMACEUTICAL MARKET SIZE, BY TYPE,  2018–2025 (USD MILLION)
     11.3 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN NORTH AMERICA
     11.4 EUROPE
             11.4.1 RELIABLE AVAILABILITY OF RAW MATERIAL AND RISING DEMAND FOR MEDICATION IS DRIVING THE GROWTH OF THE PHARMACEUTICAL GELATIN MARKET IN THE EUROPEAN REGION
                       FIGURE 33 EUROPE: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
                       TABLE 57 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
                       TABLE 58 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION,  2018–2025 (USD MILLION)
                       TABLE 59 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,  2018–2025 (USD MILLION)
                       TABLE 60 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
                       TABLE 61 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE 2018–2025 (USD MILLION)
             11.4.2 GERMANY
                       11.4.2.1 Growth of the pharmaceutical industry in Germany to drive the demand for gelatin
                                   TABLE 62 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION,  2018–2025 (USD MILLION)
                                   TABLE 63 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,  2018–2025 (USD MILLION)
                                   TABLE 64 GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,  2018–2025 (USD MILLION)
                                   TABLE 65 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE 2018–2025 (USD MILLION)
             11.4.3 FRANCE
                       11.4.3.1 High beef production in France to drive the pharmaceutical gelatin market
                                   TABLE 66 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION,  2018–2025 (USD MILLION)
                                   TABLE 67 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
                                   TABLE 68 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,  2018–2025 (USD MILLION)
                                   TABLE 69 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE 2018–2025 (USD MILLION)
             11.4.4 UK
                       11.4.4.1 Higher healthcare spending and medicine consumption fuels pharmaceutical gelatin market growth
                                   TABLE 70 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION,  2018–2025 (USD MILLION)
                                   TABLE 71 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,  2018–2025 (USD MILLION)
                                   TABLE 72 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
                                   TABLE 73 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE 2018–2025 (USD MILLION)
             11.4.5 ITALY
                       11.4.5.1 Growth of the pharmaceutical manufacturing industry to fuel the demand for gelatin
                                   TABLE 74 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 75 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
                                   TABLE 76 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,  2018–2025 (USD MILLION)
                                   TABLE 77 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE 2018–2025 (USD MILLION)
             11.4.6 SPAIN
                       11.4.6.1 Abundance of porcine raw material to drive the market for gelatin in Spain
                                   TABLE 78 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 79 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,  2018–2025 (USD MILLION)
                                   TABLE 80 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,  2018–2025 (USD MILLION)
                                   TABLE 81 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE 2018–2025 (USD MILLION)
             11.4.7 REST OF EUROPE
                       11.4.7.1 High consumption and production to drive the growth of the pharmaceutical gelatin market in Rest of Europe
                                   TABLE 82 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION,  2018–2025 (USD MILLION)
                                   TABLE 83 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,  2018–2025 (USD MILLION)
                                   TABLE 84 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,  2018–2025 (USD MILLION)
                                   TABLE 85 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE 2018–2025 (USD MILLION)
     11.5 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN EUROPE
     11.6 ASIA PACIFIC
             11.6.1 INCREASE IN CHRONIC ILLNESSES AND DEMAND FOR MEDICATION BOOSTS THE GROWTH OF THE PHARMACEUTICAL GELATIN MARKET
                       FIGURE 34 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
                       TABLE 86 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
                       TABLE 87 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION  2018–2025 (USD MILLION)
                       TABLE 88 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,  2018–2025 (USD MILLION)
                       TABLE 89 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,  2018–2025 (USD MILLION)
                       TABLE 90 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             11.6.2 CHINA
                       11.6.2.1 China’s large population and rise in chronic diseases drive the market for gelatin
                                   TABLE 91 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION  2018–2025 (USD MILLION)
                                   TABLE 92 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
                                   TABLE 93 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
                                   TABLE 94 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             11.6.3 JAPAN
                       11.6.3.1 Increasing aging population drives the market for pharmaceutical gelatin
                                   TABLE 95 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION  2018–2025 (USD MILLION)
                                   TABLE 96 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
                                   TABLE 97 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
                                   TABLE 98 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             11.6.4 INDIA
                       11.6.4.1 The booming pharmaceutical industry in the country propels the growth of the pharmaceutical gelatin market
                                   TABLE 99 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION)
                                   TABLE 100 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
                                   TABLE 101 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
                                   TABLE 102 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             11.6.5 REST OF ASIA PACIFIC
                       11.6.5.1 Australian and Vietnamese pharmaceutical industries drive the demand for pharmaceutical gelatin
                                   TABLE 103 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION)
                                   TABLE 104 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,  2018–2025 (USD MILLION)
                                   TABLE 105 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,  2018–2025 (USD MILLION)
                                   TABLE 106 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE,  2018–2025 (USD MILLION)
     11.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN THE ASIA PACIFIC REGION
     11.8 REST OF THE WORLD
             TABLE 107 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION  2018–2025 (USD MILLION)
             TABLE 108 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE,  BY APPLICATION  2018–2025 (USD MILLION)
             TABLE 109 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,  2018–2025 (USD MILLION)
             TABLE 110 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE,  BY FUNCTION,  2018–2025 (USD MILLION)
             TABLE 111 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE,  2018–2025 (USD MILLION)
             11.8.1 LATIN AMERICA
                       11.8.1.1 High availability of raw material drives the growth of the pharmaceutical gelatin market in Latin America
                                   TABLE 112 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION  2018–2025 (USD MILLION)
                                   TABLE 113 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,  2018–2025 (USD MILLION)
                                   TABLE 114 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,  2018–2025 (USD MILLION)
                                   TABLE 115 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             11.8.2 MIDDLE EAST & AFRICA
                       11.8.2.1 Rising popularity of halal gelatin drives the growth of the pharmaceutical gelatin market in the Middle East
                                   TABLE 116 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION)
                                   TABLE 117 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,  2018–2025 (USD MILLION)
                                   TABLE 118 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,  2018–2025 (USD MILLION)
                                   TABLE 119 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE,  2018–2025 (USD MILLION)
     11.9 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN THE REST OF THE WORLD

12 COMPETITIVE LANDSCAPE (Page No. - 149)
     12.1 OVERVIEW
               FIGURE 35 KEY DEVELOPMENTS IN THE GLOBAL PHARMACEUTICAL GELATIN MARKET, 2017–2020
               FIGURE 36 MARKET EVALUATION FRAMEWORK: EXPANSIONS DOMINATED THE MARKET IN 2018 AND 2019
     12.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
     12.3 PRODUCT BENCHMARKING
     12.4 PHARMACEUTICAL GELATIN MARKET:  GEOGRAPHICAL ASSESSMENT
     12.5 COMPETITIVE SITUATIONS AND TRENDS
               TABLE 120 PRODUCT LAUNCHES (2018-2020)
               TABLE 121 EXPANSIONS (2018–2019)
               TABLE 122 ACQUISITIONS (2018)
               TABLE 123 AGREEMENTS (2017)
               TABLE 124 OTHER DEVELOPMENTS (2020)

13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 156)
     13.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY
     13.2 PHARMACEUTICAL GELATIN MARKET SHARE
               FIGURE 39 PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYERS (2019)
     13.3 COMPETITIVE LEADERSHIP MAPPING
             13.3.1 STARS
             13.3.2 EMERGING LEADERS
             13.3.3 PERVASIVE
             13.3.4 EMERGING COMPANIES
                       FIGURE 40 PHARMACEUTICAL GELATIN MARKET: COMPANY EVALUATION MATRIX, 2019
     13.4 COMPANY PROFILES
(Business and financial overview, Products offered, Recent developments, SWOT analysis, and MNM view)
             13.4.1 DARLING INGREDIENTS INC.
                       FIGURE 41 DARLING INGREDIENTS INC.: COMPANY SNAPSHOT (2019)
             13.4.2 NITTA GELATIN INC.
                       FIGURE 42 NITTA GELATIN INC: COMPANY SNAPSHOT (2020)
             13.4.3 TESSENDERLO GROUP
                       FIGURE 43 TESSENDERLO GROUP: COMPANY SNAPSHOT (2019)
             13.4.4 GELITA AG
             13.4.5 WEISHARDT
             13.4.6 TROBAS GELATINE B.V.
             13.4.7 LAPI GELATINE S.P.A
             13.4.8 INDIA GELATINE & CHEMICALS LTD.
                       FIGURE 44 INDIA GELATINE & CHEMICALS LTD.: COMPANY SNAPSHOT (2020)
             13.4.9 GELNEX INDUSTRIA E COMERCIO LTDA
             13.4.10 JUNCA GELATINES SL
             13.4.11 ITALGELATINE S.P.A.
             13.4.12 XIAMEN GELKEN GELATIN CO. LTD.
             13.4.13 GELCO INTERNATIONAL
             13.4.14 HENAN BOOM GELATIN CO. LTD.
             13.4.15 BAOTOU DONGBAO BIO-TECH CO. LTD.
                          FIGURE 45 BAOTOU DONGBAO BIO-TECH CO. LTD: COMPANY SNAPSHOT (2019)
             13.4.16 ASPIRE PHARMACEUTICALS
             13.4.17 NORLAND PRODUCTS, INC.
             13.4.18 GELTECH CO. LTD.
             13.4.19 GELIKO LLC
             13.4.20 KENNEY & ROSS LIMITED

*Details on Business and financial overview, Products offered, Recent developments, SWOT analysis, and MNM view might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 186)
     14.1 INSIGHTS OF INDUSTRY EXPERTS
     14.2 DISCUSSION GUIDE
     14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL
     14.4 AVAILABLE CUSTOMIZATIONS
     14.5 RELATED REPORTS
     14.6 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

Secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the pharmaceutical gelatin market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the pharmaceutical gelatin market. The primary sources from the demand side included industry experts, procurement and purchase managers in pharmaceutical companies and gelatin capsule and tablet manufacturing companies.

Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Pharmaceutical Gelatin Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by application, by source, by function, by type and by region).

Data Triangulation

After arriving at the market size, the total pharmaceutical gelatin market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

Objectives of the Study

  • To define, describe, analyze, and forecast the size of the pharmaceutical gelatin market on the basis of application, source, function, type, and region
  • To provide detailed information on the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the size of the market segments with respect to North America, Europe, Asia Pacific, and the Rest of the World (RoW)
  • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies2
  • To track and analyze competitive developments such as product launches, expansions, acquisitions, agreements, and other developments in the market
  • To benchmark players within the pharmaceutical gelatin market using the Competitive Leadership Mapping framework which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific pharmaceutical gelatin market into South Korea, Australia, New Zealand, and other countries
  • Further breakdown of the Latin American pharmaceutical gelatin market into Brazil, Mexico, and other countries
COVID-19

Get in-depth analysis of the COVID-19 impact on the Pharmaceutical Gelatin Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Pharmaceutical Gelatin Market

Request For Special Pricing
Report Code
PH 7750
Published ON
Sep, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Gelatin Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home